{"name":"Clarus Ventures","permalink":"clarus-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/clarus-ventures","homepage_url":"http://www.clarusventures.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617.949.2200","description":"Venture capital firm","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri Apr 10 16:36:07 UTC 2009","updated_at":"Mon Jun 22 07:39:33 UTC 2009","overview":"<p>Clarus Ventures is a life sciences venture capital firm founded by a team of accomplished investment professionals with extensive and complementary industry backgrounds which have enabled them to establish a long history of success in creating value.  Their deep relationships with world thought leaders and decision makers allow this team to identify unique investment opportunities and shepherd them to maturity. Clarus augments its core expertise of investing in biopharmaceuticals and medical technology companies with the deep and diverse expertise of the team in research and development, commercialization, business development and operations management at the global level.  Clarus has $1.2 billion of assets under management across two lifesciences dedicated funds</p>","image":{"available_sizes":[[[150,82],"assets/images/resized/0005/0042/50042v1-max-150x150.png"],[[181,100],"assets/images/resized/0005/0042/50042v1-max-250x250.png"],[[181,100],"assets/images/resized/0005/0042/50042v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"101 Main Street Suite 1210","address2":"","zip_code":"02142","city":"Cambridge","state_code":"MA","country_code":"USA","latitude":42.36233,"longitude":-71.081527}],"relationships":[{"is_past":false,"title":"Managing Director","person":{"first_name":"Nicholas","last_name":"Galakatos","permalink":"nicholas-galakatos","image":{"available_sizes":[[[107,150],"assets/images/resized/0005/0051/50051v1-max-150x150.jpg"],[[112,156],"assets/images/resized/0005/0051/50051v1-max-250x250.jpg"],[[112,156],"assets/images/resized/0005/0051/50051v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Principal","person":{"first_name":"Finny","last_name":"Kuruvilla","permalink":"finny-kuruvilla","image":{"available_sizes":[[[107,150],"assets/images/resized/0005/0050/50050v1-max-150x150.jpg"],[[112,156],"assets/images/resized/0005/0050/50050v1-max-250x250.jpg"],[[112,156],"assets/images/resized/0005/0050/50050v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Director","person":{"first_name":"Dennis","last_name":"Henner","permalink":"dennis-henner","image":{"available_sizes":[[[107,150],"assets/images/resized/0005/0052/50052v1-max-150x150.jpg"],[[112,156],"assets/images/resized/0005/0052/50052v1-max-250x250.jpg"],[[112,156],"assets/images/resized/0005/0052/50052v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Director","person":{"first_name":"Kurt","last_name":"Wheeler","permalink":"kurt-wheeler","image":null}}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://venturebeat.com/2009/04/08/aerovance-inhales-38m-for-asthma-drugs/","source_description":"Aerovance inhales $38M for asthma drugs","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":7,"company":{"name":"Aerovance","permalink":"aerovance","image":{"available_sizes":[[[150,75],"assets/images/resized/0004/0827/40827v1-max-150x150.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-250x250.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.freshnews.com/news/164877/nanostringÂ®-technologies-closes-30-million-series-c-financing-accelerate-commercializati","source_description":"NANOSTRINGÂ® TECHNOLOGIES CLOSES $30 MILLION SERIES C FINANCING TO ACCELERATE THE COMMERCIALIZATION OF ITS LEADING EXPRESSION PROFILING PRODUCTS","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":14,"company":{"name":"NanoString Technologies","permalink":"nanostring-technologies","image":{"available_sizes":[[[150,42],"assets/images/resized/0004/8857/48857v1-max-150x150.png"],[[207,58],"assets/images/resized/0004/8857/48857v1-max-250x250.png"],[[207,58],"assets/images/resized/0004/8857/48857v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2007/03/28/aerovance-asthma-treatment-company-finishes-raising-60m/","source_description":"Aerovance, asthma treatment company, finishes raising $60M","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":3,"funded_day":28,"company":{"name":"Aerovance","permalink":"aerovance","image":{"available_sizes":[[[150,75],"assets/images/resized/0004/0827/40827v1-max-150x150.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-250x250.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.taligentherapeutics.com/press/080201Taligen_Series%20B.pdf","source_description":"Taligen Therapeutics Secures Series B Financing","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":1,"company":{"name":"Taligen Therapeutics","permalink":"taligen-therapeutics","image":{"available_sizes":[[[130,59],"assets/images/resized/0005/0041/50041v1-max-150x150.png"],[[130,59],"assets/images/resized/0005/0041/50041v1-max-250x250.png"],[[130,59],"assets/images/resized/0005/0041/50041v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.mitsuiventures.com/en/investment/news/2008/20081006.html","source_description":"Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of LocteronÂ® in Hepatitis C","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":6,"company":{"name":"Biolex Therapeutics","permalink":"biolex-therapeutics","image":{"available_sizes":[[[150,50],"assets/images/resized/0005/0190/50190v1-max-150x150.png"],[[250,84],"assets/images/resized/0005/0190/50190v1-max-250x250.png"],[[263,89],"assets/images/resized/0005/0190/50190v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/esbatech-rounds-additional-22m-series-b/2008-08-07","source_description":"ESBATech rounds up $22M in second round","raised_amount":22000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":8,"funded_day":7,"company":{"name":"ESBATech","permalink":"esbatech","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/0466/50466v1-max-150x150.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-250x250.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/lycera-corp-series-a-36m/","source_description":"Lycera Corp.: Series A $36M","raised_amount":36000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":5,"company":{"name":"Lycera","permalink":"lycera","image":{"available_sizes":[[[150,71],"assets/images/resized/0005/0591/50591v1-max-150x150.png"],[[219,105],"assets/images/resized/0005/0591/50591v1-max-250x250.png"],[[219,105],"assets/images/resized/0005/0591/50591v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://deals.venturebeat.com/2008/07/03/pearl-therapeutics-ups-its-first-round-funding/","source_description":"Pearl Therapeutics ups its first round funding","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":7,"funded_day":3,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://deals.venturebeat.com/2007/04/18/sientra-device-maker-for-plastic-surgery-raises-85m/","source_description":"Sientra, device maker for plastic surgery, raises $85M","raised_amount":85000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":18,"company":{"name":"Sientra","permalink":"sientra","image":{"available_sizes":[[[150,63],"assets/images/resized/0005/9574/59574v1-max-150x150.png"],[[165,70],"assets/images/resized/0005/9574/59574v1-max-250x250.png"],[[165,70],"assets/images/resized/0005/9574/59574v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://venturebeat.com/2007/12/06/pelikan-tech-raises-69m-for-finger-friendly-diabetes-testing/","source_description":"Pelikan Tech to push â€œfinger friendlyâ€ diabetes testing","raised_amount":69000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":12,"funded_day":6,"company":{"name":"Pelikan Technologies","permalink":"pelikan-technologies","image":{"available_sizes":[[[150,55],"assets/images/resized/0004/1895/41895v1-max-150x150.png"],[[157,58],"assets/images/resized/0004/1895/41895v1-max-250x250.png"],[[157,58],"assets/images/resized/0004/1895/41895v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.sec.gov/Archives/edgar/data/1375151/000137515109000006/xslFormDX01/primary_doc.xml","source_description":"SEC D","raised_amount":35957968,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":5,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/virdante-pharmaceuticals-inc-series-a-30m/","source_description":"Virdante Pharmaceuticals, Inc.: Series A $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":25,"company":{"name":"Virdante Pharmaceuticals","permalink":"virdante-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0006/4176/64176v1-max-150x150.jpg"],[[250,71],"assets/images/resized/0006/4176/64176v1-max-250x250.jpg"],[[278,79],"assets/images/resized/0006/4176/64176v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ophthotech-nabs-30m-round-fund-amd-trial/2009-12-15?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Ophthotech nabs $30M round to fund AMD trial","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":15,"company":{"name":"Ophthotech","permalink":"ophthotech","image":{"available_sizes":[[[150,25],"assets/images/resized/0006/9859/69859v1-max-150x150.jpg"],[[250,42],"assets/images/resized/0006/9859/69859v1-max-250x250.jpg"],[[368,62],"assets/images/resized/0006/9859/69859v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.zogenix.com/index.php/news/zogenix-raises-18-million-in-preferred-stock-financing/","source_description":"Zogenix Raises $18 Million in Preferred Stock Financing","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":9,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2010/01/neomend-closes-30m-funding-round.html","source_description":"Neomend Closes $30M Funding Round","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":27,"company":{"name":"Neomend","permalink":"neomend","image":{"available_sizes":[[[150,43],"assets/images/resized/0007/5202/75202v1-max-150x150.png"],[[225,65],"assets/images/resized/0007/5202/75202v1-max-250x250.png"],[[225,65],"assets/images/resized/0007/5202/75202v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/pearl-therapeutics-inc-series-c-15m/","source_description":"Pearl Therapeutics, Inc.: Series C $15M","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":5,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.oxfordimmunotec.com/Default.aspx?DN=f673006f-0d53-4065-b191-e485e3981ae5","source_description":"Oxford Immunotec Completes $40M Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":29,"company":{"name":"Oxford Immunotec","permalink":"oxford-immunotec","image":{"available_sizes":[[[150,60],"assets/images/resized/0007/1001/71001v2-max-150x150.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-250x250.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.variationbiotech.com/VBI%20Financing%20Press%20Release%20v1.4.pdf","source_description":"Variation Biotechnologies Secures US$35.7 Million in Series A Financing to Fund Innovative Vaccine Platform","raised_amount":35700000,"raised_currency_code":"USD","funded_year":2007,"funded_month":1,"funded_day":4,"company":{"name":"Variation Biotechnologies","permalink":"variation-biotechnologies","image":{"available_sizes":[[[150,64],"assets/images/resized/0007/9952/79952v1-max-150x150.jpg"],[[250,108],"assets/images/resized/0007/9952/79952v1-max-250x250.jpg"],[[259,112],"assets/images/resized/0007/9952/79952v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://esbatech.com/pr/press_releases/esbatech_press_02082006.pdf","source_description":"ESBATech Closes USD 41M Series B Venture Financing","raised_amount":41000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":2,"company":{"name":"ESBATech","permalink":"esbatech","image":{"available_sizes":[[[150,54],"assets/images/resized/0005/0466/50466v1-max-150x150.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-250x250.png"],[[239,87],"assets/images/resized/0005/0466/50466v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.zogenix.com/index.php/news/zogenix-inc-raises-60-million-in-series-a-venture-financing-names-board-of-directors/","source_description":"Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":28,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.sarcode.com/about.html","source_description":"SARcode secured $25 million in financing ","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":12,"funded_day":1,"company":{"name":"SARcode Bioscience","permalink":"sarcode-corporation","image":{"available_sizes":[[[150,104],"assets/images/resized/0008/4418/84418v5-max-150x150.jpg"],[[250,174],"assets/images/resized/0008/4418/84418v5-max-250x250.jpg"],[[450,313],"assets/images/resized/0008/4418/84418v5-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/catabasis-nails-39m-series-diabetes-programs/2010-04-21","source_description":"Catabasis lands $39M Series A for diabetes programs","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":21,"company":{"name":"Catabasis Pharmaceuticals","permalink":"catabasis-pharmaceuticals","image":{"available_sizes":[[[150,37],"assets/images/resized/0010/6512/106512v1-max-150x150.png"],[[250,62],"assets/images/resized/0010/6512/106512v1-max-250x250.png"],[[398,99],"assets/images/resized/0010/6512/106512v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/oxford-immunotec-ltd-series-d-26m/","source_description":"Oxford Immunotec, Ltd.: Series D $26M","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":4,"company":{"name":"Oxford Immunotec","permalink":"oxford-immunotec","image":{"available_sizes":[[[150,60],"assets/images/resized/0007/1001/71001v2-max-150x150.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-250x250.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss","source_description":"FerroKin rounds up $12M for iron overload treatment  Read more: FerroKin rounds up $12M for iron overload treatment - FierceBiotech http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss#ixz","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":18,"company":{"name":"FerroKin Biosciences","permalink":"ferrokin-biosciences","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap funding Report","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":12,"company":{"name":"NanoString Technologies","permalink":"nanostring-technologies","image":{"available_sizes":[[[150,42],"assets/images/resized/0004/8857/48857v1-max-150x150.png"],[[207,58],"assets/images/resized/0004/8857/48857v1-max-250x250.png"],[[207,58],"assets/images/resized/0004/8857/48857v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/tetralogic-nabs-32m-round-lead-cancer-therapy/2010-08-10?utm_medium=rss&utm_source=rss","source_description":"TetraLogic nabs $32M round for lead cancer therapy  Read more: TetraLogic nabs $32M round for lead cancer therapy","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":10,"company":{"name":"TetraLogic Pharmaceuticals","permalink":"tetralogic-pharmaceuticals","image":{"available_sizes":[[[150,43],"assets/images/resized/0009/8561/98561v1-max-150x150.png"],[[250,72],"assets/images/resized/0009/8561/98561v1-max-250x250.png"],[[270,78],"assets/images/resized/0009/8561/98561v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.achillion.com/releasedetail.cfm?ReleaseID=500371","source_description":"Achillion Announces Private Placement of $50 Million","raised_amount":50100000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":18,"company":{"name":"Achillion Pharmaceuticals","permalink":"achillion-pharmaceuticals","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/0871/60871v2-max-150x150.png"],[[250,56],"assets/images/resized/0006/0871/60871v2-max-250x250.png"],[[303,69],"assets/images/resized/0006/0871/60871v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.zogenix.com/index.php/news/zogenix-secures-35-million-debt-facility-and-raises-15-million-investment-capital/","source_description":"Zogenix Secures $35 Million Debt Facility And Raises $15 Million Investment Capital","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":13,"company":{"name":"Zogenix","permalink":"zogenix","image":{"available_sizes":[[[100,23],"assets/images/resized/0006/0696/60696v1-max-150x150.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-250x250.png"],[[100,23],"assets/images/resized/0006/0696/60696v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.tyrx.com/Collateral/Documents/TyRx%20English-US/MKT-23-092%20TYRX%20Funding112910-%20Final.pdf","source_description":"TYRX, Inc. Raises $20 Million in Private Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":12,"funded_day":8,"company":{"name":"TyRx Pharma","permalink":"tyrx-pharma","image":{"available_sizes":[[[150,42],"assets/images/resized/0011/3429/113429v1-max-150x150.png"],[[160,45],"assets/images/resized/0011/3429/113429v1-max-250x250.png"],[[160,45],"assets/images/resized/0011/3429/113429v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.aeriepharma.com/20110307_pressrelease.html","source_description":"Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":3,"funded_day":7,"company":{"name":"Aerie Pharmaceuticals","permalink":"aerie-pharmaceuticals","image":{"available_sizes":[[[93,122],"assets/images/resized/0012/4935/124935v1-max-150x150.png"],[[93,122],"assets/images/resized/0012/4935/124935v1-max-250x250.png"],[[93,122],"assets/images/resized/0012/4935/124935v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/07/sarcode-bioscience-closes-44m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"SARcode Bioscience Closes $44M Series B Financing","raised_amount":44000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":18,"company":{"name":"SARcode Bioscience","permalink":"sarcode-corporation","image":{"available_sizes":[[[150,104],"assets/images/resized/0008/4418/84418v5-max-150x150.jpg"],[[250,174],"assets/images/resized/0008/4418/84418v5-max-250x250.jpg"],[[450,313],"assets/images/resized/0008/4418/84418v5-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/08/restoration-robotics-raises-41m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Restoration Robotics Raises $41M in Series C Financing","raised_amount":41000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":3,"company":{"name":"Restoration Robotics","permalink":"restoration-robotics","image":{"available_sizes":[[[150,90],"assets/images/resized/0005/9449/59449v3-max-150x150.jpg"],[[250,150],"assets/images/resized/0005/9449/59449v3-max-250x250.jpg"],[[450,270],"assets/images/resized/0005/9449/59449v3-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/10/cleave-biosciences-raises-42m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Cleave Biosciences Raises $42M in Series A Financing","raised_amount":42000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":11,"company":{"name":"Cleave Biosciences","permalink":"cleave-biosciences","image":null}}},{"funding_round":{"round_code":"d","source_url":"http://www.xconomy.com/seattle/2011/11/07/nanostring-grabs-20m-from-ge-former-genzyme-ceo-to-pursue-molecular-diagnostics/","source_description":"NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":7,"company":{"name":"NanoString Technologies","permalink":"nanostring-technologies","image":{"available_sizes":[[[150,42],"assets/images/resized/0004/8857/48857v1-max-150x150.png"],[[207,58],"assets/images/resized/0004/8857/48857v1-max-250x250.png"],[[207,58],"assets/images/resized/0004/8857/48857v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.catabasispharma.com/pdfs/Catabasis_Final_Financing_PR_12.13.11.pdf","source_description":"Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":13,"company":{"name":"Catabasis Pharmaceuticals","permalink":"catabasis-pharmaceuticals","image":{"available_sizes":[[[150,37],"assets/images/resized/0010/6512/106512v1-max-150x150.png"],[[250,62],"assets/images/resized/0010/6512/106512v1-max-250x250.png"],[[398,99],"assets/images/resized/0010/6512/106512v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/06/oxford-immunotec-raises-28m-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Oxford Immunotec Raises $28M in Equity Financing","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":18,"company":{"name":"Oxford Immunotec","permalink":"oxford-immunotec","image":{"available_sizes":[[[150,60],"assets/images/resized/0007/1001/71001v2-max-150x150.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-250x250.jpg"],[[241,97],"assets/images/resized/0007/1001/71001v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/11/pearl-therapeutics-raises-65m-series-financing.html","source_description":"Pearl Therapeutics Raises $65M in Series D Financing","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":13,"company":{"name":"Pearl Therapeutics","permalink":"pearl-therapeutics","image":{"available_sizes":[[[150,56],"assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],[[180,68],"assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://www.reuters.com/article/2012/12/03/idUS110449+03-Dec-2012+BW20121203","source_description":"NanoString Technologies Completes $15.3 Million Series E Financing","raised_amount":15300000,"raised_currency_code":"USD","funded_year":2012,"funded_month":12,"funded_day":3,"company":{"name":"NanoString Technologies","permalink":"nanostring-technologies","image":{"available_sizes":[[[150,42],"assets/images/resized/0004/8857/48857v1-max-150x150.png"],[[207,58],"assets/images/resized/0004/8857/48857v1-max-250x250.png"],[[207,58],"assets/images/resized/0004/8857/48857v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}